Comment from People for the Ethical Treatment of Animals

Summary: PETA (represented by its Regulatory Toxicology Department) supports the draft guidance on New Approach Methodologies (NAMs) and suggests improvements to enhance regulatory clarity and efficiency. They argue for specific updates that emphasize human-relevant outcomes over animal-test concordance, recommend clearer pathways for sponsor-FDA engagement, and advocate for a flexible, evidence-based validation framework.